Abstract:Objective: To investigate if PUMA gene transfection could increase the sensitivity of breast cancer cells(MCF-7) on Epirubicin-induced apoptosis.Methods: PUMA-pCDNA3,which contains full length PUMA cDNA or-pCDNA3,was transfected into the human breast cancer cell line MCF-7 by using lipofectamine.G418 selection was used to select positive cells.MCF-7,MCF-7/PUMA,and MCF-7/pCDNA3 cells were respectively treated with serial concentrations of Epirubicin(0.01 μmol/L to 100 μmol/L).MTT assay was performed to determine the cell survival rate in each group.IC50 of Epirubicin was then calculated.TUNEL and FCM were employed to investigate cell apoptosis.Western blot was performed to detect PUMA protein expression.Results: The Epirubicin IC50 values of MCF-7,MCF-7/PUMA,and MCF-7/pCDNA3 cells were(13±1.4),(1.8±0.2),and(10.7±1.3) μmol/L,respectively.The sensitivity of MCF-7/PUMA cells had a 7.2-fold increase.The Epirubicin-induced apoptosis of MCF-7 cells behaved in a dose-dependent manner.The apoptosis of MCF-7/ PUMA cells was more prominent than that of MCF-7 and MCF-7/ pCDNA3 cells.At a low concentration(0.1 μmol/L),Epirubicin could only slightly induce MCF-7/ pCDNA3 cells [(1.15±0.26)%] and MCF-7 cells [(0.9±0.24)%],as well as the apoptosis in MCF-7/PUMA cells [(6.44±1.46)%].At a high concentration,Epirubicin(1.0 μmol/L) could induce apoptosis in all groups.The apoptotic rate was significantly higher in MCF-7/PUMA cells [(35.47±9.36)%] than in MCF-7/ pCDNA3 cells [(15.2±5.17)%] and in MCF-7 cells [(12.6±3.73)%],both P<0.01).Results obtained from FCM and TUNELwere the same.PUMAprotein expression was significantly higher in MCF-7/PUMAcells than in MCF-7 and MCF-7/pCDNA3 cells.Conclusion: PUMA gene transfection greatly enhances the sensitivity of MCF-7 cells during Epirubicin-induced apoptosis.

Construction of expression plasmid of the mutant PUMA and its expression in Hela cells

Apoptotic Effects of the Exogenous PTEN Tumor Suppressor Gene on Human Mucoepidermoid Carcinoma Cell Line

Construction of Recombinant Adenovirus Containing P53 Up-Regulated Modulator of Apoptosis and Its Effect on Pancreatic Cancer in Vitro and in Vivo

Delivery of Puma Apoptosis Gene Using Polyethyleneimine-Smcc-Tat/Dna Nanoparticles: Biophysical Characterization and in Vitro Transfection into Malignant Melanoma Cells

Establishment of an expression system of Puma gene targeting ovarian carcinoma COC1 cells

Construction and Expression of Eukaryotic Expression Vector for I Kappa B Alpha Mutant Gene

PUMA gene inhibits the growth of PC-3 Pancreatic carcinoma cells

[Expression of Modified Humanized Immunoapoptotic Protein and Its Specific Killing Effect on HER2-positive Tumor Cells].

The Expression of PUMA in Colon Carcinoma Cells and Its Effect in Cell Apoptosis

Recombinant adenovirus containing PUMA gene regulated by human telomerase reverse transcriptase promoter transfected into ovarian cancer COC1 cells

Radiation-inducible promoters mediated PUMA gene in the treatment of xenograft of human tongue squamous in naked mice

Construction and Identification of Recombinant Adeno-Associated Virus Vector Mediating the Expression of the Derepressing P73 Peptide-P53 (N37)

Effects of Exogenous PUMA on Proliferation and Apoptosis of Non-Small Cell Lung Cancer A549 Cells

Construction of Eukaryotic Expression Vector of Wild-type/Transmembrane TNF and The Effect on Cardiomyocyte Apoptosis

Construction and identification of eukaryotic expression vector for mutant PCNA

A feasibility study on gene therapy of pancreatic carcinoma with Ad-PUMA.

Construction of recombinant plasmid containing hTERT promoter and PE38KDEL gene and its anti-apoptosis effect on human pancreatic cancer cell MiaPaCa2

Construction and identification of fusion gene of NT4-p53(N37)-HA2-TAT

Effect of PUMA gene transfection in breast cancer cells (MCF-7) on enhancing the sensitivity of epirubicin-induced apoptosis

Soluble Expression of Recombinant Apoptin Fused with Mutant Cell-penetrating Peptide

PUMA, a potent killer with or without p53